MedGenome’s OncoPept wins MedTech Breakthrough AwardsJuly 16, 2018
MedGenome, a leading genomics driven research and diagnostics company, announced that its OncoPep platform was named the winner of the 2018 MedTech Breakthrough Awards for ‘Best Overall Genomics Solution’.
An advanced genomics-based solution designed to accelerate cancer immune-oncology research, OncoPept platform is used by researchers to help identify biomarkers aimed at delivering personalized therapies, including more durable, improved and responsive cancer immunotherapy treatments.
It leverages on a novel T cell receptor binding algorithm to predict personalised cancer vaccine candidates, and provides a high-throughput multi-dimensional view of the tumour microenvironment using NGS (Next Generation Sequencing) based solutions.
The MedTech Breakthrough Awards recognize the top companies, people, platforms and products in the health, fitness and medical technology industries today.